Precigen (PGEN) Operating Expenses (2012 - 2026)
Precigen (PGEN) posted quarterly Operating Expenses of $29.2 million for Q1 2026, up 22.18% year-over-year from $23.9 million in Q1 2025, and up 11.49% quarter-over-quarter from $26.2 million in Q4 2025.
Precigen (PGEN) Operating Expenses (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Operating Expenses for 15 consecutive years, with $29.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 22.18% year-over-year to $29.2 million; the TTM figure through Mar 2026 stood at $125.5 million (down 8.67% YoY), while the FY2025 annual figure was $120.2 million, down 13.5% from the prior year.
- Operating Expenses grew to $29.2 million in Q1 2026 per PGEN's latest filing, from $26.2 million in the prior quarter.
- Across five years, Operating Expenses topped out at $61.6 million in Q2 2024 and bottomed at $22.2 million in Q3 2024.
- Historically, Operating Expenses has averaged $29.2 million across 5 years, with a median of $26.2 million in 2025.
- Annual changes were most pronounced in 2024 — Operating Expenses surged 168.96% — and 2025, when it tumbled 47.01%.
- Precigen's Operating Expenses stood at $23.6 million in 2022, then soared by 50.48% to $35.5 million in 2023, then fell by 16.21% to $29.7 million in 2024, then dropped by 11.7% to $26.2 million in 2025, then increased by 11.49% to $29.2 million in 2026.
- Business Quant data shows PGEN's Operating Expenses at $29.2 million in Q1 2026, $26.2 million in Q4 2025, and $37.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Precigen | 2.18 Bn | 2.18 Bn | 52.17 Mn | 32.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.34 Mn |
| Mar 31, 2026 | 29.25 Mn |
| Dec 31, 2025 | 26.23 Mn |
| Sep 30, 2025 | 37.40 Mn |
| Jun 30, 2025 | 32.62 Mn |
| Mar 31, 2025 | 23.94 Mn |
| Dec 31, 2024 | 29.71 Mn |
| Sep 30, 2024 | 22.22 Mn |
| Jun 30, 2024 | 61.56 Mn |
| Mar 31, 2024 | 25.48 Mn |
| Dec 31, 2023 | 35.45 Mn |
| Sep 30, 2023 | 22.32 Mn |
| Jun 30, 2023 | 22.89 Mn |
| Mar 31, 2023 | 25.33 Mn |
| Dec 31, 2022 | 23.56 Mn |
| Sep 30, 2022 | 24.34 Mn |
| Jun 30, 2022 | 27.07 Mn |
| Mar 31, 2022 | 27.67 Mn |
| Dec 31, 2021 | 25.56 Mn |
| Sep 30, 2021 | 24.86 Mn |